EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 383 filers reported holding EXELIXIS INC in Q1 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $385,000 | -17.9% | 19,200 | 0.0% | 0.03% | -28.9% |
| Q3 2020 | $469,000 | +2.9% | 19,200 | 0.0% | 0.04% | -6.2% |
| Q2 2020 | $456,000 | +38.2% | 19,200 | 0.0% | 0.05% | +11.6% |
| Q1 2020 | $330,000 | +21.3% | 19,200 | +24.7% | 0.04% | +53.6% |
| Q4 2019 | $272,000 | 0.0% | 15,400 | 0.0% | 0.03% | -9.7% |
| Q3 2019 | $272,000 | -20.9% | 15,400 | -4.3% | 0.03% | -18.4% |
| Q2 2019 | $344,000 | -13.8% | 16,095 | -3.9% | 0.04% | -17.4% |
| Q1 2019 | $399,000 | +16.7% | 16,755 | -3.7% | 0.05% | +2.2% |
| Q4 2018 | $342,000 | +11.0% | 17,400 | 0.0% | 0.04% | +36.4% |
| Q3 2018 | $308,000 | -17.9% | 17,400 | 0.0% | 0.03% | -23.3% |
| Q2 2018 | $375,000 | +2.5% | 17,400 | +5.1% | 0.04% | -2.3% |
| Q1 2018 | $366,000 | -31.5% | 16,550 | -5.7% | 0.04% | -32.3% |
| Q4 2017 | $534,000 | +22.5% | 17,550 | -2.5% | 0.06% | +16.1% |
| Q3 2017 | $436,000 | -1.8% | 18,000 | 0.0% | 0.06% | -8.2% |
| Q2 2017 | $444,000 | +13.8% | 18,000 | 0.0% | 0.06% | +10.9% |
| Q1 2017 | $390,000 | +45.5% | 18,000 | 0.0% | 0.06% | +34.1% |
| Q4 2016 | $268,000 | +16.5% | 18,000 | 0.0% | 0.04% | +13.9% |
| Q3 2016 | $230,000 | – | 18,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |